Hilary A. Tindle, M.D., M.P.H.

Hilary Tindle, M.D., M.P.H., is Associate Professor of Medicine with tenure in the Division of General Internal Medicine, founding Director of the Vanderbilt Center for Tobacco Addiction and Lifestyle (ViTAL), William Anderson Spickard, Jr, MD, Chair in Medicine, and a member of the American Society of Clinical Investigation (ASCI). She leads a translational research program to develop and test interventions for nicotine dependence and since 2014 has served as principal investigator (PI/MPI) on five R01 grants and a U01 grant. She has authored/co-authored 195 publications, publishing in high-impact general audience journals (e.g., JAMA/JAMA family) and addiction medicine journals (e.g., Nicotine and Tobacco Research, Addiction). Her epidemiologic research charting life course smoking exposure and risk of lung cancer and cardiovascular disease in the Framingham Heart Study has led to guideline changes in risk assessment. She has been invited to present her work locally, nationally, and internationally, and since 2015 has served as an NIH grant reviewer, including standing membership in the study section Interventions to Prevent and Treat Addiction (IPTA), and as an ad-hoc reviewer for the Canadian Institutes of Health Research (CIHR) and the Wellcome Trust. She led the implementation chapter of the National Cancer Institute’s Tobacco Control Monograph #23, part of the Cancer Moonshot Initiative, and serves as a Senior Editor of the forthcoming Surgeon General’s Report on tobacco use among people with mental health conditions and substance use disorders. She has mentored 30 trainees, most of whom continue in research-related careers, and is the contact PI of a newly-awarded NIDA-K12 proposal to train the next generation of addiction researchers. As the founding Medical Director of the VUMC Tobacco Treatment Service she has overseen 13,000 consults since 2015, leveraging these clinical programs to recruit over 1400 VUMC patients to cancer prevention trials.